5Sagnella GA.Mearement and significance of circulating natriuretic peptides in cardiovascular disease.Clin Sci,1998,95:519-529.
6Hystad ME,Geiran OR,Attramadal H,et al.Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.Acta Physiol Scand,2001,171:395-403.
7Goto T,Takase H,Toriyama T,et al.Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure.Heart,2003,89:1303-1307.
8Hobbs RE,Miller LW,Bott-Silverman C,et al.Hemodynamic effects of a single Intravenous Injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Am J Cardiol,1996,78:896
9Mills RM,LeJemtel TH,Horton DP,et al.Sustainded hemodynamic effects of an Infusion of nesiritide(human B-type natriuretic peptide)in heart failure.J Am Coll Cardiol,1999,34:155-162.
10Colucci WS,Elkayam U,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated congestive heart failure.N Engl J Med,2000,343:896.
3Witteles RM, Kao D, Christopherson D, et al. Impact of nesiritide on renal function in patients with acute decom- pensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical tri- al[J]. JAm Coll Cardiol, 2007,50( 19).: 1 835.
4Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: exec- utive summary (update 2005) :The Task Force for the Di- agnosis and Treatment of Chronic Heart Failure of the Eu- ropean Society of Cardiology[J]. Eur Hea't J, 2005, 26 (11):1 115.
5George I, Morrow B, Xu K, et al. Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury[J]. Am J Physiol Heart Circ Physiol, 2009,297 (2) : H708.
6Publication Committee for the VMAC Investigators (Va- sodilatation in the Management of Acute CHF). Intrave- nous nesiritide vs nitroglycerin for treatment of decompen- sated congestive heart failure : a randomized controlled tri- al[J]. JAMA, 2002,287(12) : 1 531.
7Dandamudi S, Chen HH. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompen- sated heart failure[J]. Expert Rev Cardiovasc Ther, 2012, 10(5):557.
8Wang D J, Dowling TC, Meadows D, et al. Nesiritide does not improve renal function inpatients with chronic heart failure and worsening scram crcatinine[J]. Circulau- on, 2004,110(12):i 620.
9Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial[J]. JAM_A, 2005,294(13) : 1 625.
10Shah MR, Califf RM, Nohria A, et al. The STARBRITE trial: a randomized, pilot study of B-type natriuretic pep- tide-guided therapy in patients with advanced heart failure [J]. JCardFail, 2011,17(8) :613.
